Paul Daruwala - Net Worth and Insider Trading

Paul Daruwala Net Worth

The estimated net worth of Paul Daruwala is at least $148,097 dollars as of 2024-11-13. Paul Daruwala is the COO of Cidara Therapeutics Inc and owns about 11,055 shares of Cidara Therapeutics Inc (CDTX) stock worth over $148,097. Details can be seen in Paul Daruwala's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Daruwala has not made any transactions after 2022-09-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Paul Daruwala

To

Paul Daruwala Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul Daruwala owns 1 companies in total, including Cidara Therapeutics Inc (CDTX) .

Click here to see the complete history of Paul Daruwala’s form 4 insider trades.

Insider Ownership Summary of Paul Daruwala

Ticker Comapny Transaction Date Type of Owner
CDTX Cidara Therapeutics Inc 2022-09-12 Chief Medical Officer

Paul Daruwala Latest Holdings Summary

Paul Daruwala currently owns a total of 1 stock. Paul Daruwala owns 11,055 shares of Cidara Therapeutics Inc (CDTX) as of September 12, 2022, with a value of $148,097.

Latest Holdings of Paul Daruwala

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CDTX Cidara Therapeutics Inc 2022-09-12 11,055 13.40 148,097

Holding Weightings of Paul Daruwala


Paul Daruwala Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul Daruwala has made a total of 4 transactions in Cidara Therapeutics Inc (CDTX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Cidara Therapeutics Inc is the sale of 810 shares on September 12, 2022, which brought Paul Daruwala around $11,015.

Insider Trading History of Paul Daruwala

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul Daruwala Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul Daruwala Ownership Network

Ownership Network List of Paul Daruwala

No Data

Ownership Network Relation of Paul Daruwala

Insider Network Chart

Paul Daruwala Owned Company Details

What does Cidara Therapeutics Inc do?

Who are the key executives at Cidara Therapeutics Inc?

Paul Daruwala is the Chief Medical Officer of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , Chief Medical Officer Taylor Sandison , and director & President & CEO Jeffrey Stein .

Cidara Therapeutics Inc (CDTX) Insider Trades Summary

Over the past 18 months, Paul Daruwala made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 30,407 shares made by Leslie Tari , a net sale of 40,379 shares made by Taylor Sandison , and a net purchase of 58,000 shares made by Jeffrey Stein .

In summary, during the past 3 months, insiders sold 1,833 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 1,833 shares. During the past 18 months, 7,751 shares of Cidara Therapeutics Inc (CDTX) were sold and 11,000 shares were bought by its insiders, resulting in a net purchase of 3,249 shares.

Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cidara Therapeutics Inc Insider Transactions

No Available Data

Paul Daruwala Mailing Address

Above is the net worth, insider trading, and ownership report for Paul Daruwala. You might contact Paul Daruwala via mailing address: 6310 Nancy Ridge Dr, San Diego Ca 92121.